Corrigendum to “Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]

[This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].

Saved in:

Bibliographic Details
Published in:	JTO clinical and research reports Vol. 6; no. 10; p. 100892
Main Authors:	Garassino, Marina C., Gadgeel, Shirish, Novello, Silvia, Halmos, Balazs, Felip, Enriqueta, Speranza, Giovanna, Hui, Rina, Garon, Edward B., Horinouchi, Hidehito, Sugawara, Shunichi, Rodriguez-Abreu, Delvys, Reck, Martin, Cristescu, Razvan, Aurora-Garg, Deepti, Loboda, Andrey, Lunceford, Jared, Kobie, Julie, Ayers, Mark, Piperdi, Bilal, Pietanza, M. Catherine, Paz-Ares, Luis
Format:	Journal Article
Language:	English
Published:	United States Elsevier Inc 01.10.2025 Elsevier
Subjects:	Hematology, Oncology, and Palliative Medicine
ISSN:	2666-3643, 2666-3643
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	[This corrects the article DOI: 10.1016/j.jtocrr.2022.100431.].
Bibliography:	erratum
ISSN:	2666-3643 2666-3643
DOI:	10.1016/j.jtocrr.2025.100892